News & Updates

Counselling provided by a pharmacist enhances the caregiver’s knowledge about juvenile idiopathic arthritis (JIA) and may even reduce costs for patients with JIA, according to a Singapore study.

In the phase III ICONIC-LEAD trial, selective blockade of the interleukin(IL)-23 receptor with the targeted oral peptide icotrokinra is associated with higher rates of skin clearance and symptom relief in adults and adolescents with moderate-to-severe plaque psoriasis.